MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Novel combination of serum microRNA for detecting breast cancer in the early stage

(2016) Akihiko Shimomura et al.   CANCER SCIENCE

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

(2016) Koji Nakamura et al.   Molecular Cancer

ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells

(2016) N Luo et al.   Cell Death & Disease

The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment

(2015) Rong Tang et al.   CARCINOGENESIS

Differentially methylated microRNAs in prediagnostic samples of subjects who developed breast cancer in the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort

(2015) Francesca Cordero et al.   CARCINOGENESIS

Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs

(2015) Sara R. Selitsky et al.   mBio

MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1

(2015) Kai-Xuan Sun et al.   Journal of Ovarian Research

The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer

(2015) Yingying Zhou et al.   Journal of Ovarian Research

ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression

(2015) Wen-feng Gou et al.   Oncotarget

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma

(2015) Yasuto Kinose et al.   Oncotarget

The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer

(2015) Yang Li et al.   Oncotarget

ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer

(2015) Feng Zhang et al.   Oncotarget

The clinical and diagnostic role of microRNAs in ovarian carcinoma

(2014) Ben Davidson et al.   GYNECOLOGIC ONCOLOGY

Role of mesenchymal cells in the natural history of ovarian cancer: a review

(2014) Cyril Touboul et al.   Journal of Translational Medicine

Clinically Relevant microRNAs in Ovarian Cancer

(2014) Shu Zhang et al.   MOLECULAR CANCER RESEARCH

The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression

(2014) L Lv et al.   Cell Death & Disease

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

(2013) Chifumi Ohyagi-Hara et al.   AMERICAN JOURNAL OF PATHOLOGY

Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer

(2013) Da Yang et al.   CANCER CELL

Aberrant Expression miR-196a Is Associated With Abnormal Apoptosis, Invasion, and Proliferation of Pancreatic Cancer Cells

(2013) Minghao Liu et al.   PANCREAS

Truncation of inhibitor of growth family protein 5 effectively induces senescence, but not apoptosis in human tongue squamous cell carcinoma cell line

(2013) Lin Qi et al.   TUMOR BIOLOGY

The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects

(2011) Feng Zhang et al.   PLoS One

MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines

(2011) Smriti Kumar et al.   Journal of Ovarian Research

The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas☆

(2010) Hua-chuan Zheng et al.   HUMAN PATHOLOGY

The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression☆

(2010) Ya-nan Xing et al.   HUMAN PATHOLOGY

Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma

(2010) Beyhan Cengiz et al.   INTERNATIONAL JOURNAL OF CANCER

Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma

(2010) Xiaohan Li et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Allelic Loss of the ING Gene Family Loci Is a Frequent Event in Ameloblastoma

(2010) Silvia S. Borkosky et al.   ONCOLOGY RESEARCH

ING function in apoptosis in diverse model systemsThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB’s 51st Annual Meeting – Epigenetics and Chromatin Dynamics, and has undergone the Journal’s usual peer review process.

(2009) Sitar Shah et al.   Biochemistry and Cell Biology

MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy

(2009) Todd Boren et al.   GYNECOLOGIC ONCOLOGY

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via  5-Integrin, which Is a Therapeutic Target

(2008) K. Sawada et al.   CANCER RESEARCH

MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer

(2008) N. Yang et al.   CANCER RESEARCH

MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN

(2008) H. Yang et al.   CANCER RESEARCH